Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access August 9, 2011

Hepatitis C virus genotypes in injecting drug users from Romania

  • Camelia Sultana EMAIL logo , Codruta Vagu , Aura Temereanca , Camelia Grancea , Josefina Slobozeanu and Simona Ruta
From the journal Open Medicine


Due to the increasing number of infections related to injecting drug use, both the pattern of hepatitis C virus (HCV) transmission, and the circulating genotypes in Europe have changed. As there are little available data in this respect for Romania, the aim of our study was a preliminary analysis of the distribution of HCV genotypes circulating among injecting drug users (IDUs). Of the 45 IDUs evaluated (86.7% men, mean age − 27.6 ± 3.7 years, mean age at first drug use − 17.5 ± 3.9 years), 88.9% presented anti-HCV antibodies, with higher rates in those with an injecting history of more than 10 years; 57.8% of the subjects had detectable HCV viral load. Only 6.7% had markers of chronic hepatitis B infection, and none had anti-HIV antibodies. While HCV subtype 1b is still prevalent (in 50% of the viraemic subjects), other subtypes begin to emerge, especially in younger patients (1a — in 23.1%, 4 — in 11.5%, 3a — in 7.7% of the cases). These data indicate the possibility of major shifts in the distribution of the dominant subtype, underlining the need for close surveillance of HCV infections in IDUs, who can act as a bridging group toward the general population.

[1] European Centre for Disease Prevention and Control, Surveillance and Prevention of Hepatitis B and C in Europe, ECDC, Stockholm, 2010 Search in Google Scholar

[2] European Centre for Disease Prevention and Control, Annual Epidemiological Report on Communicable Diseases in Europe 2010, ECDC, Stockholm, 2010 Search in Google Scholar

[3] Esteban J.I., Sauleda S., Quer J., The changing epidemiology of hepatitis C virus infection in Europe, J. Hepatol., 2008, 48, 148–162 in Google Scholar PubMed

[4] European Monitoring Centre for Drugs and Drug Addiction, Annual report on the state of the drugs problem in Europe, EMCDDA, Lisbon, 2010 Search in Google Scholar

[5] Gheorghe L., Csiki I.E., Iacob S., Gheorghe C., Smira R., Regep L., The prevalence and risk factors of hepatitis C virus infection in adult population in Romania: a nationwide survey 2006–2008, J. Gastrointestin. Liver Dis., 2010, 19(4), 373–379 Search in Google Scholar

[6] European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and National Antidrug Agency from Romania (NAA), National report on drugs situation for Romania, New developments, trends and in-depth information on selected issues, REITOX, Bucharest, 2010 Search in Google Scholar

[7] United Nation on Drugs and Crime, HIV, HBV and HCV behavioral surveillance survey among injecting drug users in Bucharest, Romania, Speed Promotion, Bucharest, 2010 Search in Google Scholar

[8] Rantala M., Van de Laar M., Surveillance and epidemiology of hepatitis B and C in Europe — a review, Eurosurveillance, 2008, 10.2807/ese.13.21.18880-enSearch in Google Scholar PubMed

[9] Grigorescu M., HCV genotype 1 is almost exclusively present in Romanian patients with chronic hepatitis C, J. Gastrointestin. Liver Dis., 2009, 18(1), 45–50 Search in Google Scholar

[10] Sutton A.J., Hope V.D., Mathei C., Mravcik V., Sebakova H., Vallejo F., et al., A comparison between the force of infection estimates for bloodborne viruses in injecting drug user populations across the European Union: a modelling study, J. Viral Hepatitis, 2008,15(11), 809–816 10.1111/j.1365-2893.2008.01041.xSearch in Google Scholar PubMed

[11] UNGASS, Country Progress Report for Romania, Reporting period: January 2008–December 2009, UNGASS, Romania, 2010 Search in Google Scholar

[12] Bourlière M., Barberin J.M., Rotily M., Guagliardo V., Portal I., Lecomte L., et al., Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users, J. Viral Hepatitis, 2002, 9(1), 62–70 in Google Scholar PubMed

[13] Huppe D., Zehnter E., Mauss S., Boker K., Lutz T., Racky S., et al., Epidemiology of chronic hepatitis C in Germany-an analysis of 10,326 patients in hepatitis centres and outpatient units, Z. Gastroenterol., 2008, 46(1), 34–44 in Google Scholar PubMed

[14] Cenci M., De Soccio G., Recchia O., Prevalence of hepatitis C virus (HCV) genotypes in central Italy, Anticancer Res., 2003, 23(6D), 5129–5132 Search in Google Scholar

[15] Nēmecek V., Strunecký O., Genotypic heterogeneity of hepatitis C virus (HCV) from blood donors in the Czech Republic, Epidemiol. Mikrobiol. Imunol., 2009, 58(2), 63–72 Search in Google Scholar

[16] Chlabicz S., Flisiak R., Kowalczuk O., Grzeszczuk A., Pytel-Krolczuk B., Prokopowicz D, et al., Changing HCV genotypes distribution in Poland — Relation to source and time of infection, J.Clin. Virol., 2008, 42(2), 156–159 in Google Scholar PubMed

[17] Svirtlih N., Delic D., Simonovic J., Jevtovic D., Dokic L., Gvozdenovic E., et al., Hepatitis C virus genotypes in Serbia and Montenegro: The prevalence and clinical significance, World J. Gastroenterol., 2007, 13(3), 355–360 10.3748/wjg.v13.i3.355Search in Google Scholar PubMed PubMed Central

[18] Ahmetagić S., Salkić N., Čičkušić E., Zerem E., Mott-Divković S., Tihić N., Hepatitis C virus genotypes in chronic hepatitis C patients and in first time blood donors in Northeastern Bosnia and Herzegovina, Bosnian Journal of Basic Medical Sciences, 2009, 9(4), 278–282 10.17305/bjbms.2009.2779Search in Google Scholar PubMed PubMed Central

[19] Paintsil E., Verevochkin S.V., Dukhovlinova E., Niccolai L., Barbour R., White E., et al., Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection, Addiction., 2009, 104(11), 1881–1890 in Google Scholar PubMed PubMed Central

[20] Tallo T., Norder H., Tefanova V., Krispin T., Schmidt J., Ilmoja M., et al. Genetic characterization of hepatitis C virus strains in Estonia: fluctuations in the predominating subtype with time, J. Med. Virol., 2007, 79, 374–382 in Google Scholar PubMed

[21] Colina R., Casane D., Vasquez S., García-Aguirr L., Chunga A., Romero H., et al., Evidence of intratypic recombination in natural populations of hepatitis C virus, J. Gen. Virol., 2004, 85, 31–37 in Google Scholar

[22] Kalinina O., Norder H., Magnius L.O., Full-length open reading frame of a recombinant hepatitis C virus strain from St Petersburg: proposed mechanism for its formation, J. Gen. Virol., 2004, 85, 1853–1857 in Google Scholar

[23] Van de Laar T.J., Van der Bij A.K., Prins M., Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J. Infect. Dis., 2007, 196, 230–238 in Google Scholar

[24] Danta M., Brown D., Bhagani S., Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours, AIDS, 2007, 21, 983–991 in Google Scholar

[25] Pitigoi D., Rafila A., Pistol A., Arama V., Molagic V., Streinu-Cercel A., Trends in hepatitis B incidence in Romania, 1989–2005, Eurosurveillance, 2008, 13(1–3), 70–74 10.2807/ese.13.02.08012-enSearch in Google Scholar

[26] Paintsil E., He H., Peters C., Lindenbach B.D., Heimer R., Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users, J. Infect. Dis., 2010, 202(7), 984–990 in Google Scholar

[27] Huik K., Sadam M., Karki T., Avi R., Krispin T., Paap P., et al., CCL3L1 Copy Number is a strong genetic determinant of HIV seropositivity in caucasian intravenous drug users, J. Infect. Dis., 2010, 201(5), 730–739 in Google Scholar

[28] Ruta S.M., Matusa R.F., Sultana C., Manolescu L., Kozinetz C.A., Kline M., et al., High prevalence of hepatitis B virus markers in Romanian adolescents with HIV, Med. Gen. Med., 2005, 7, 68–72 10.1186/1758-2652-7-1-68Search in Google Scholar

[29] National AIDS Committee, Department for AIDS monitoring from Romania, Statistic data on HIV/ AIDS infection in Romania, CNLAS, Bucharest, 2010 (in Romanian) Search in Google Scholar

[30] EuroHIV, HIV/AIDS Surveillance in Europe. Midyear report 2007 No.76, French Institute for Public Health Surveillance, Saint-Maurice, 2007 Search in Google Scholar

[31] Shakarishvili A., Dubovskaya L.K., Zohrabyan L.S., St Lawrence J.S., Aral S.O., Dugasheva L.G., et al., Sex work, drug use, HIV infection, and spread of sexually transmitted infections in Moscow, Russian Federation, Lancet, 2005, 366, 57–60 in Google Scholar

[32] Jabłonowska E., Małolepsza E., Causes of death in HIV-infected patients in the region of Lodz, Poland from 1995 through 2005, Cent. Eur. J. Med., 2009, 4(2), 179–183 in Google Scholar

[33] Joint United Nations Programme on HIV/AIDS, The Changing HIV/AIDS Epidemic in Europe and Central Asia, UNAIDS, WHO Library, Geneva, 2004 Search in Google Scholar

Published Online: 2011-8-9
Published in Print: 2011-10-1

© 2011 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 1.3.2024 from
Scroll to top button